<?xml version="1.0" encoding="UTF-8"?>
<p>Replacing 3-fluoropyridine of compound 
 <bold>Vf</bold> with 3-fluorophenyl moiety, compound 
 <bold>Vd</bold> significantly increased growth inhibition against number of cancer cell lines, such as leukaemia HL-60(TB), non-small cell lung cancer HOP-92, leukaemia CCRF-CEM, leukaemia SR, and breast cancer MCF7 with percent growth inhibition of 39.17%, 41.59%, 41.82%, 44.28%, and 48.28%, respectively, compared to that of compound 
 <bold>Vf</bold> (20.72%, 17.66%, 21.84%, 7.01%, and 0.62%, respectively). In addition, compound 
 <bold>Vd</bold>, showed good to excellent activity against colon cancer HCT-116, colon cancer HT29, and leukaemia K-562 with percent growth inhibition of 57.92%, 69.56%, and 83.45%, respectively.
</p>
